Purdue startup hopes to change the way we test cancer drugs
A Purdue University scientist's nanopolymer would make it easier and cheaper for drug developers to test the effectiveness of a widely used class of cancer inhibitors.
A Purdue University scientist's nanopolymer would make it easier and cheaper for drug developers to test the effectiveness of a widely used class of cancer inhibitors.
Analytical Chemistry
Mar 16, 2011
0
0
(PhysOrg.com) -- Sanjeevi Sivasankar was looking for a better tool to study how cells adhere to each other.
Biochemistry
Nov 22, 2010
0
0
By combining an iron oxide nanoparticle, a tumor-targeting peptide, and a therapeutic nucleic acid into one construct, a team of investigators from the Massachusetts General Hospital and Harvard Medical School have created ...
Bio & Medicine
Oct 28, 2010
0
0
(PhysOrg.com) -- University of Leicester researchers have combined crime research and space-age technology in ways that could lead to the quick detection of counterfeit pharmaceuticals in a black market currently worth an ...
Analytical Chemistry
Sep 8, 2009
0
0
(PhysOrg.com) -- A new development in stem cell research has resulted from a completed study by a collaboration of scientists using the drug Rapamycin to inhibit mTOR, an intracellular protein necessary in cell proliferation. ...
Biotechnology
May 15, 2009
0
0
The ability of the Food and Drug Administration (FDA) to regulate the safety of dietary supplements using nanomaterials is severely limited by lack of information, lack of resources and the agency's lack of statutory authority ...
Bio & Medicine
Jan 14, 2009
4
0